These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8239479)

  • 1. Euglobulin lysis times: an update.
    Glassman A; Abram M; Baxter G; Swett A
    Ann Clin Lab Sci; 1993; 23(5):329-32. PubMed ID: 8239479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new euglobulin clot lysis assay for global fibrinolysis.
    Smith AA; Jacobson LJ; Miller BI; Hathaway WE; Manco-Johnson MJ
    Thromb Res; 2003; 112(5-6):329-37. PubMed ID: 15041279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 125I-fibrinogen euglobulin clot-lysis test.
    Horvath AE; Gralnick HR
    Am J Clin Pathol; 1978 Aug; 70(2):271-4. PubMed ID: 696685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
    Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
    Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of breast cancer and mastectomy on fibrinolytic activity in African women.
    Famodu ES; Fakoya AA; Barhua TA; Osime CO; Egwaikhide E; Egbagbe EE; Olu-Edo AN; Osime EO
    Afr J Reprod Health; 2006 Dec; 10(3):114-9. PubMed ID: 17518138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of moderate and strenuous daily physical activity on fibrinolytic activity of blood: possibility of plasminogen activator stores depletion.
    Keber D; Stegnar M; Keber I; Accetto B
    Thromb Haemost; 1979 Jun; 41(4):745-55. PubMed ID: 483247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Euglobulin lysis time (ELT)].
    Kaizu K; Abe M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():584-5. PubMed ID: 15658395
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of five streptokinase formulations using the euglobulin lysis test and the plasminogen activation assay.
    Couto LT; Donato JL; de Nucci G
    Braz J Med Biol Res; 2004 Dec; 37(12):1889-94. PubMed ID: 15558196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
    Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
    Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modified quantitative whole blood clot lysis method for general laboratory analysis of fibrinolysis.
    Kahn MB; Palmer S; Marlar RA; Fink L
    Thromb Res; 1990 Jul; 59(1):171-81. PubMed ID: 2119074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new device for measurement of fibrin clot lysis: application to the euglobulin clot lysis time.
    Boudjeltia KZ; Cauchie P; Remacle C; Guillaume M; Brohée D; Hubert JL; Vanhaeverbeek M
    BMC Biotechnol; 2002 May; 2():8. PubMed ID: 11985782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Euglobulin lysis time in fresh and stored samples.
    Prisco D; Paniccia R; Bandinelli B; Filippini M; Brunelli T; Zarone N; Francalanci I; Abbate R
    Am J Clin Pathol; 1994 Dec; 102(6):794-6. PubMed ID: 7801893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA).
    Trusen B; Ries M; Zenker M; Rauh M; Beinder E; Keuper H; Harms D
    Semin Thromb Hemost; 1998; 24(6):599-604. PubMed ID: 10066156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clot life span model analysis of clot growth and fibrinolysis in normal subjects: role of thrombin activatable fibrinolysis inhibitor.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):283-7. PubMed ID: 18469549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
    Watahiki Y; Scully MF; Ellis V; Kakkar VV
    Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects on the coagulation-fibrinolysis system of a single oral dose of mesoglycan at the beginning and at the end of a prolonged treatment in man].
    Blardi P; Messa G; Puccetti L; La Placa G; Ghezzi A
    Recenti Prog Med; 1995; 86(7-8):282-9. PubMed ID: 7569284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolysis in the rat after short-term aspirin therapy.
    Housholder GT; Moorrees LL
    J Oral Surg; 1980 Jun; 38(6):412-6. PubMed ID: 6929324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
    Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired fibrinolysis in premenopausal women and age-matched men with Type 2 diabetes mellitus: a pilot study.
    Brandenburg SL; Reusch JE; Felder KK; Nelson-Wong E; Lindenfeld J; Manco-Johnson M; Regensteiner JG
    J Investig Med; 2002 Mar; 50(2):110-5. PubMed ID: 11930948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.